OPAC CAPITAL - Creating Trade Opportunities For International Clients, We are Brokerage top financial solutions provider resolving all types of financial problems by helping clients find, create and execute original ideas "as well as offer astute financial advice and world-class service."
Monday, 7 August 2023
Sage Therapeutics shares plunge 49% after FDA depression-drug decision
Sage Therapeutics shares plunge 49% after FDA depression-drug decision
from MarketWatch.com - MarketWatch Breaking News Bulletins https://ift.tt/jBF2rXU
via OPAC CAPITAL
No comments:
Post a Comment